139 related articles for article (PubMed ID: 6214992)
1. Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin.
Lutz B; Mogabgab W; Holmes B; Pollock B; Beville R
Antimicrob Agents Chemother; 1982 Jul; 22(1):10-4. PubMed ID: 6214992
[TBL] [Abstract][Full Text] [Related]
2. Preliminary report comparing piperacillin and carbenicillin for complicated urinary tract infections.
Swarifi R; Lee M; Ojeda L; Tabib M
J Urol; 1982 Oct; 128(4):755-8. PubMed ID: 6216344
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin v Carbenicillin in the therapy for serious infections.
Marier RL; Sanders CV; Faro S; Janney A; Williams WW; Derks F; Aldridge KE
Arch Intern Med; 1982 Oct; 142(11):2000-5. PubMed ID: 6215008
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin sodium: antibacterial spectrum, pharmacokinetics, clinical efficacy, and adverse reactions.
Fortner CL; Finley RS; Schimpff SC
Pharmacotherapy; 1982; 2(6):287-99. PubMed ID: 6220262
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of piperacillin therapy for infection.
Pancoast S; Prince AS; Francke EL; Neu HC
Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
[TBL] [Abstract][Full Text] [Related]
6. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
Cox CE
J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility patterns of bacteria following therapy with piperacillin.
Marier RL; Marinaccio AT; Sanders CV; Aldridge KE; Mitchell JW
J Antimicrob Chemother; 1982 Feb; 9 Suppl B():85-91. PubMed ID: 6460737
[No Abstract] [Full Text] [Related]
8. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse.
Simon GL; Snydman DR; Tally FP; Gorbach SL
Antimicrob Agents Chemother; 1980 Jul; 18(1):167-70. PubMed ID: 6448020
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of piperacillin.
Thadepalli H; Rao B; White D; Bach VT
Chemotherapy; 1980; 26(5):377-83. PubMed ID: 6446449
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin: a review of clinical experience.
Gooding PG; Clark BJ; Sathe SS
J Antimicrob Chemother; 1982 Feb; 9 Suppl B():93-9. PubMed ID: 6460738
[No Abstract] [Full Text] [Related]
12. Comparative efficacy of piperacillin versus carbenicillin for complicated urinary tract infections.
Sharifi R; Lee M; Ojeda L
Urol Int; 1984; 39(6):345-51. PubMed ID: 6395464
[TBL] [Abstract][Full Text] [Related]
13. Piperacillin therapy for serious bacterial infections.
Winston DJ; Murphy W; Young LS; Hewitt WL
Am J Med; 1980 Aug; 69(2):255-61. PubMed ID: 6447455
[No Abstract] [Full Text] [Related]
14. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
Eliopoulos GM; Moellering RC
Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
[TBL] [Abstract][Full Text] [Related]
15. Piperacillin against clinical isolates: antimicrobial profile and clinical role.
McAllister TA
J Antimicrob Chemother; 1982 Feb; 9 Suppl B():75-84. PubMed ID: 6460736
[No Abstract] [Full Text] [Related]
16. Timentin versus piperacillin in the therapy of serious urinary tract infections.
File TM; Tan JS; Salstrom SJ; Johnson L
Am J Med; 1985 Nov; 79(5B):91-5. PubMed ID: 4073102
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
Monif GR; Clark PR; Shuster JJ; Baer H
Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
[TBL] [Abstract][Full Text] [Related]
18. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
[TBL] [Abstract][Full Text] [Related]
19. [Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
Manncke K; Springsklee M; Heizmann WR; Sonntag HG
Med Klin (Munich); 1991 Sep; 86(9):454-60. PubMed ID: 1943983
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study.
Huang NN; Palmer J; Keith H; Schidlow D; Braverman S; Goldberg M
J Antimicrob Chemother; 1983 May; 11 Suppl B():205-14. PubMed ID: 6352603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
